FDA Approves Pfizer’s BRAFTOVI + MEKTOVI for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer Read more
Cellares Announces Expanded Agreement with Bristol Myers Squibb to Include Second CAR-T Program in Cellares’ Technology Adoption Partnership Program Read more
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline Read more
Forxiga met primary endpoint in T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed to date Read more
Japan’s Ministry of Health, Labour and Welfare approves GSK’s Arexvy, the country’s first respiratory syncytial virus (RSV) vaccine for older adults Read more
FDA Accepts for Priority Review Merck’s Supplemental New Drug Application for WELIREG (belzutifan) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) Read more
European Commission Approves Pfizer’s LITFULO for Adolescents and Adults With Severe Alopecia Areata Read more